期刊文献+

口服药物治疗妊娠期肝内胆汁淤积症116例临床分析 被引量:2

Oral Medication Intrahepatic Cholestasis Analysis of 116 Cases
下载PDF
导出
摘要 目的探讨ICP的口服药物治疗效果,为患者选用经济适用的治疗。方法选取我院2009年1月至2011年6月期间确诊为ICP且在门诊仅接受口服熊去氧胆酸胶囊(优思弗)药物治疗的患者116例,分析这些患者的治疗效果及妊娠结局。结果①终止妊娠的孕周为(36.5±1.5)周。②患者的血清胆红素、肝转氨酶和胆汁酸水平较治疗前明显下降甚至完全恢复正常。差异有统计学意义(P<0.01)。③围生儿结局如早产、羊水粪染、新生儿窒息率等与我院同期正常孕妇的结局相比无差异。结论 ICP患者,在门诊口服熊去氧胆酸治疗有确切疗效。建议选用该方法,既方便病员又能减轻经济负担。 Objective To explore the effect of oral drug treatment for ICP, choose the most affordable treatment for the patients. Methods Select the hospital in January 2009 and June 2011 to the hospital to check and received only oral ursodeoxycholic acid capsules (Ursofalk) therapy in patients with 116 cases of ICP, Analyze the treatment and pregnancy outcomes of these patients. Results (1)Termination of pregnancy gestational age of 36.5±1.5 weeks. (2)Serum bilirubin, liver transaminase and bile acid levels decreased significantly compared with before treatment. Thedifference was statistically significant(P〈 0.01). Perinatal outcome such as premature,stained amniotic fluid, neonatal asphyxia were no significant difference in pregnancy outcomes with the general hospital pregnants in the same period. Conclusion In the treatment of ICP, there are exact effects in the treatments of oral ursodeoxycholic acid of outpatients It issuggested that we should choose the method, it will bring convenience to the patients and reduce the financial burden at the same time.
出处 《中国医药指南》 2011年第35期271-273,共3页 Guide of China Medicine
关键词 ICP 治疗方法 妊娠结局 ICP Oral medication Pregnancy outcomes
  • 相关文献

参考文献7

二级参考文献50

共引文献479

同被引文献20

  • 1刘玉凌,乔福元.熊去氧胆酸治疗妊娠期肝内胆汁淤积症的研究进展[J].医药导报,2005,24(2):137-139. 被引量:10
  • 2刘玉芳,邢爱耘.熊去氧胆酸治疗妊娠期肝内胆汁淤积症的循证评价[J].中华妇幼临床医学杂志(电子版),2006,2(5):281-282. 被引量:4
  • 3张传荣.中西医综合治疗妊娠期肝内胆汁淤积症104例临床分析[J].安徽医药,2006,10(11):867-868. 被引量:4
  • 4曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:2163-2169. 被引量:621
  • 5PATA O,VARDARELI E, OZCAN A, et al.lntrahepatie ch- olestasis of pregnancy: correlation of preterm delivery with bile acids [ J ]. Turk J Gastroenterol, 2011,22 (6) : 602- 605. 被引量:1
  • 6RODRIGUE C M,MARIN J G,BRITES D.Bile acid pattren in meconium are influenced by cholestasis of pregnancy and not atered by ursodcoxycholic acid treatment[ J] .Gut, 1999, 45(3) :446-452. 被引量:1
  • 7Azzaroli F, Turco L, Lisotti A, et al. The pharmacological management of Intrahepatic cholestasis of pregnancy[J~. Curr Clin Pharmacol,2011,6(1) .-12 17. 被引量:1
  • 8Stieger B, Geier A. Genetic variations of bile salt trans porters as predisposing factors for drug induced eholesta- sis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis[J~. Expert Opin Drug MetabToxicol,2011,7(4):411-425. 被引量:1
  • 9Papacleovoulou G, Abu-Hayyeh S, Nikolopoulou E, et al. Maternal cholestasis during pregnancy programs metabol ic disease in offspring [J ~. J Clin Invest, 2013,123(7) 3172-3181. 被引量:1
  • 10Martineau M, Papacleovoulou G, Abu-Hayyeh S, et al. Cholestatic pregnancy is associated with reduced placen- tal 11~HSD2 expression[J]. Placenta, 2014, as (1) : 37- 4a. 被引量:1

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部